Novo Nordisk’s latest outlook upgrade and Wegovy pill sales beat gave the stock a fresh lift, while Binance Futures data showed a constructive but not unanimous futures bias. Price is now pressing … (Read More)Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here